S. aureus strains |
|
|
NCTC 8325-4 |
Commonly utilized laboratory strain cured of known prophages |
28 |
RN4220 |
NCTC 8325-4 r-; capable of stably maintaining recombinant plasmids |
19 |
SA-K1712 |
NCTC 8325-4 with norA disrupted by tetK
|
16 |
SA-K1748 |
MDR mutant of SA-K1712; GrlA S80F |
16 |
SA-K1748-P |
SA-K1748 + pALC2073 |
This study |
SA-K1748-R |
SA-K1748 + pK434 |
This study |
SA-K1748 mepA- |
mepA disrupted by fusion with lacZ
|
This study |
SA-K2068 |
MDR mutant of NCTC 8325-4 |
15 |
SA-K2068-P |
SA-K2068 + pALC2073 |
This study |
SA-K2068-R |
SA-K2068 + pK434 |
This study |
SA-K2068 mepA- |
mepA disrupted by fusion with lacZ
|
This study |
SA-K1758 |
NCTC 8325-4 with norA deleted |
31 |
SA-K1758-P |
SA-K1758 + pALC2073 |
This study |
SA-K1758-A |
SA-K1758 + pK436 |
This study |
SA-K1758-B |
SA-K1758 + pK438 |
This study |
SA-K1758-AB |
SA-K1758 + pK440 |
This study |
Plasmids |
|
|
pALC2073 |
S. aureus vector containing a tetracycline-inducible promoter controlling expression of cloned genes, Cmr
|
1 |
pAZ106 |
Suicide vector used to disrupt mepA
|
17 |
pK434 |
pALC2073-mepR
|
This study |
pK436 |
pALC2073-mepA
|
This study |
pK438 |
pALC2073-mepB
|
This study |
pK440 |
pALC2073-mepAB
|
This study |